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Abstract
Adult skeletal muscle in vertebrates contains myoendothelial cells that express both myogenic and endothelial markers, and
which are able to differentiate into myogenic cells to contribute to muscle regeneration. In spite of intensive research
efforts, numerous questions remain regarding the role of cytokine signalling on myoendothelial cell differentiation and
muscle regeneration. Here we used Hirudo medicinalis (Annelid, leech) as an emerging new model to study myoendothelial
cells and muscle regeneration. Although the leech has relative anatomical simplicity, it shows a striking similarity with
vertebrate responses and is a reliable model for studying a variety of basic events, such as tissue repair. Double
immunohistochemical analysis were used to characterize myoendothelial cells in leeches and, by injecting in vivo the
matrigel biopolymer supplemented with the cytokine Vascular Endothelial Growth Factor (VEGF), we were able to isolate
this specific cell population expressing myogenic and endothelial markers. We then evaluated the effect of VEGF on these
cells in vitro. Our data indicate that, similar to that proposed for vertebrates, myoendothelial cells of the leech directly
participate in myogenesis both in vivo and in vitro, and that VEGF secretion is involved in the recruitment and expansion of
these muscle progenitor cells.
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Introduction
Adult stem cells from tissues such as muscle, bone marrow, or the
brain, exhibit the ability to differentiate into diverse cell types
according to the cues provided by the tissue in which they have been
reintroduced [1,2]. For example, hematopoietic stem cells (HSCs)
can not only produce all blood cell lineages, but also exhibit
developmental plasticity, differentiating, for example, into cardiac
muscle or vascular endothelium [3,4] with appropriate stimuli.
Myogenic and endothelial (myoendothelial) cell progenitors have
been identified in the interstitial spaces of murine skeletal muscle.
These primitive cells, which are distinct from satellite cells, are
located outside of the basal lamina, express both endothelial and
myogenic cell markers and are able to differentiate into myogenic
cells, contributing to new fibre formation [5–7]. Adult muscle tissue
therefore appears to contain a common type of pluripotent stem
cells, such as hematopoietic and mesenchymal-like cells [8]. These
cells are activated during tissue repair, differentiating in a context–
specific manner, presumably in response to growth factors and
signals provided by the host tissue [2].
Among the cytokines produced by different tissues, VEGF
(Vascular Endothelial Growth Factor) mediates its biological
effects by binding to a series of transmembrane tyrosine kinase
receptors, principally VEGFR-1 and VEGFR-2 [9]. It plays roles
as a potent proangiogenic molecule, as a mitogen and survival
factor or as a chemoattractant for endothelial cells [10–12] under
physiological and pathological conditions. Moreover, it has been
demonstrated that VEGF165 (the most abundant and biologically
active isoform) is a potent chemoattractant for CD34 positive cells
and it is critical for the migration of CD34+ stem cells from the
bone marrow into tumors [13].
Despite extensive investigation and characterization of stem
cells showing molecular and developmental relationships between
endothelial and myogenic cells in vertebrates, no reports have
been published that explore this phenomenon in invertebrates.
We have previously demonstrated that in the leech Hirudo
medicinalis, the angiogenic process is regulated by several of the
principal growth factors and receptors (in particular VEGF and the
VEGFRs) that coordinate neovascularization in vertebrates [14,15].
Moreover, a localized and continuous exposure to VEGF by
implantation of a VEGF-Hydron pellet within the muscle wall [15]
induced a massive stimulation of circulating cells, as previously
described for conditions producing elevated VEGF levels in humans
[16]. In H. medicinalis, these cells were CD34+, and were localized in
the vessel lumen as well as disseminated into the extracellular matrix
(ECM) [17]. These cells were able to differentiate, in situ, into
PLoS ONE | www.plosone.org 1 October 2009 | Volume 4 | Issue 10 | e7652
endothelial cells in a manner that reflects that of murine circulating
endothelial progenitor cells [18]. Interestingly, CD34+/Flt-1+/
CD452 endothelial cells isolated from skeletal muscle have also
been found to differentiate into skeletal muscle fibres [19].
During leech wound healing, new vessels are formed in
otherwise avascular tissues. The botryoidal tissue is composed of
two different cell types, granular botryoidal cells and flattened
endothelial-like cells that are organized in cords or clusters,
sometimes surrounding occasional small lacunae localized in the
loose connective tissue between the gut and the body wall sac. In
wounded animals, the botryoidal tissue undergoes a transition
from cluster/cord-like structures to a hollow, tubular architecture
typical of pre-vascular structures that gives rise to new capillary
vessels [17]. Concurrently, groups of small, closely-associated cells
became evident in the centre of the immature vessel lumen. They
are initially adherent to the vessel wall and appear to be precursor
cells. As the vessel grows, these circulating precursor cells lose cell-
cell contacts to move freely within the lumen. Most of the
circulating precursor cells are channelled into the wounded area
via the new vessels, where they extravasate and disperse into the
connective tissue. These circulating precursor cells in the leech
express many of the same markers as those commonly used to
identify vertebrate ECs and hematopoietic stem cells [17].
Here we examined whether in leeches, like in vertebrates, the
vessel-associated precursors cells, dispersed in the connective
tissue of the body wall muscle, are responsible for muscle
regeneration during wound healing repair. Our data show that in
the leech a population of cells, showing features in common with
myoendothelial cells found in vertebrate skeletal muscle [6,7],
are dispersed in the ECM surrounding the muscle fibres. These
cells coexpress both myogenic (MyoD and desmin) and
endothelial markers (Flk-1, VE-cadherin, CD34 and CD31)
and are recruited by the growth factor VEGF into the area
undergoing regeneration. This specific population of cells was
isolated and cultured by using the biopolymer matrigel
supplemented with VEGF [20] and its differentiation in muscle
cells was assessed in vivo and in vitro.
Results
Identification of Leech Myoendothelial Precursors Cells
Morphological, immunohistochemical and biochemical
analysis. The unlesioned leech body wall (Fig. 1A) is essentially
made up of an epithelium wrapping grouped muscle fibres
embedded in a loose connective tissue. Following tissue damage,
wound healing initiates with an inflammatory phase [21,22]
characterised by a massive migration of macrophages and
fibroblasts (Fig. 1B), followed by fibroplasia and angiogenesis,
with the formation of a network of blood vessels spanning the
entire body wall [17]. Approximately 1 month after injury, small
new muscle fibres are visible in the abundant newly synthesised
collagen matrix (Fig. 1C, D). Based on these observations, we
examined whether myoendothelial cells, of both endothelial and
myogenic origin, could be involved in muscle regeneration in
leeches, similar to that observed in vertebrates [6,7,23]. Sections of
both unlesioned and injured leeches were immunostained with
antibodies against antigens characteristic of myogenic, endothelial
or macrophages cells. Muscle cells expressed the myosin heavy
chain (MyHC) (Fig. 1E, F) and the muscle regulatory factor (MRF)
MyoD (Fig. 1G, H) both in control and injured animals. To
confirm the specificity of antigen recognition by the anti-MyoD
and anti-MyHC, antibodies, Western blot analyses were
performed to compare a protein extract from the body muscles
of leeches with extracts from rat muscle used as a positive control.
The anti-MyHC A4.1025 antibody revealed a band of 200 KDa
both in rat and in leech samples (Fig. 1I lanes 2 and 3,
respectively). The anti-MyoD antibody detected a band of the
expected 34 kDa size in rat (Fig. 1J, lane 2) and a band of
approximately 37 kDa in leech (Fig. 1J, lane 3). Omission of the
primary antibodies did not stain any proteins in the leech extracts
(Fig. 1I and 1J lanes 4).
Cells expressing the typical endothelial cell markers CD34, VE-
cadherin, Flk-1 and CD31 [6,7,15,17,20] and the macrophage cell
marker CD68 [17,20,24] were found dispersed in the ECM
surrounding the groups of muscle cells in the control unlesioned
animals (Fig. 2A–E) and close to the wound healing region of injured
leeches (Fig. 2F–J). We never observed the expression of these
markers in leech muscle, as clearly visible in unlesioned animals
(Fig. 2A–F) or in other leech tissues such as gut (data not shown).
Some of the CD34+ (Fig. 2A, F), VE-cadherin+ (Fig. 2B, G), Flk-1+
(Fig. 2C, H) and CD31+ (Fig. 2D, I) were also MyoD+. In contrast,
the CD68+ cells, mainly localized in the lesioned/regenerating area,
were MyoD2 (Fig. 2E, J). Cells that were CD31+/MyoD+ were
38.964.4% of the CD31+ cells, CD34+/MyoD+ 39.862% of the
CD34+ cells, VE-cadherin+/MyoD+ 3964% of the VE-cadherin+
cells and Flk-1+/MyoD+ 38.964.3% of the Flk-1+ cells in unlesioned
leeches, while the percentage of these cells rose to 71.363%,
71.466%, 70.763% and 75.363.1% respectively, in injured animals
(p,0.01, n=4). The CD68+/MyoD+ cells were 360.2% in
unlesioned and 0.860.8% of the CD68+ cells (the differences were
not statistically significant, n=4) in wounded leeches (Fig. 2K).
The antibodies against the endothelial markers CD31 and CD34
in protein extracts of leech tissue stained proteins of approximately
120 kDa for CD31 (Fig. 2L, lane 2) and 140 kDa for CD34 (Fig. 2L,
lane 3). These molecular weights correspond to those of the murine
counterparts. Omission of the primary antibodies did not stain any
proteins in the leech extracts (Fig. 2L, lanes 5). Confirmation of
antibody specificity by western blotting for CD68, Ve-cadherin and
Flk-1 have been previously published [15,17,25].
Dil-Ac-LDL up-take. In vertebrates, co-expression of
endothelial and myogenic markers in combination with acetylated
low-density lipoporotein (Ac-LDL) conjugated with the
fluorochrome probe Dil (Dil-Ac-LDL) uptake is associated with a
population of myoendothelial cells located in the muscular
interstitial spaces and involved in muscle regeneration [6,7]. We
carried out experiments to establish whether also in leeches a
specific population of myoendothelial cells could be involved in
leech muscle regeneration. To address this, Dil-Ac-LDL (which is
taken up preferentially by endothelial cells and macrophages via the
‘‘scavenger cell pathway’’ of LDL metabolism [6,7,26]) was used as
a vital marker to stain and to follow the fate of those cells
interspersed in the interstitial space of muscles in unlesioned leeches,
or localized close to the injured region in wounded leeches. After
4 h from injection of Dil-Ac-LDL in both the control healthy and in
the injured leeches, cryosections of unlesioned (Fig. 3A) and injured
animals (Fig. 3B, C) were analysed. Numerous cells dispersed
among the groups of muscle cells in unlesioned leech (Fig. 3A) or
localised in the injured, regenerating area of the muscular sac
(Fig. 3B) showed uptake of the fluorochrome-conjugated probe Dil-
Ac-LDL, indicating scavenger receptor expression typical of
endothelial cells and macrophages. DIL-Ac-LDL uptake was also
detected in the cytoplasm of many circulating precursors cells found
within the lumen of newly formed vessels (Fig. 3C). Notably, mature
muscle cells did not take up Ac-LDL, (Fig. 3A, B).
VEGF Is Involved in the Recruitment of Dil-Ac-LDL+ Cells
We previously reported that VEGF165 in the leech promoted
not only angiogenesis and recruitment of hematopoietic precursor
Muscle Regeneration in Leech
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cells [15] but also the migration of Dil-, CD34+ cells into injected
matrigel biopolymer supplemented with VEGF [15,20]. Since in
vertebrates the CD34 is a marker associated not only with
hematopoietic precursors/endothelial cells, but also with the
population of myoendothelial cells involved in muscle regeneration
[6,7], we sought to determine whether in the leech a similar
population of myoendothelial cells, recruited by VEGF, could be
involved in leech muscle regeneration. We first assessed the ability
of VEGF to influence mobilization of the Dil-Ac-LDL+ cells in vivo.
Consistent with this, angiogenesis and migration of cells was
stimulated by VEGF injection in the body wall muscle of leeches
that had been previously injected with Dil-Ac-LDL. One week
after VEGF and Dil-Ac-LDL injections, numerous vessels (Fig. 3D)
and cells incorporating Dil-Ac-LDL (Fig. 3E) were clearly visible in
Figure 1. Morphological, immunoistochemical and biochemical assays of unlesioned (A, E, G) and injured (B–D, F, H) leech muscle
body wall. (A) Cross cryosection of the body wall of an unlesioned leech. Under the epithelium muscular layers, circularly, obliquely and
longitudinally oriented are visible. (B) Cross cryosection of the body wall of a leech one week after a surgical lesion. A plug (arrowhead) formed by
migrating cells is visible under the epithelium. (C, D) Detail at the optical (C) and electron (D) microscope level of the regenerating area after one
month from injury. Small muscle cells (arrowhead in C), with their contractile material organized in sarcomeres (arrowhead in D) are surrounded by an
abundant collagen matrix (ECM in C and D). (E–H) The muscle cells are stained by MyHC (in red) and MyoD (in green) antibodies. Nuclei are
counterstained with DAPI (blue in E, F). e: epithelium; m: muscle; arrowhead: plug region. (I, J): Western blot analysis. Expression of MyHC A4.1025 (I)
and MyoD (J) in extracts of unlesioned H. medicinalis body walls or rat muscle used as positive control. The antibody A4.1025 anti-MyHC detects a
band of about 200 kDa both in rat (I, lane 2) and in leech (I, lane 3). The antibody anti-MyoD recognizes the expected band of about 34 kDa in rat (J,
lane2) and a band of 37 kDa in leech (J, lane 3). The molecular weights are in accordance with those of the corresponding vertebrate molecules.
Lanes 1 in I, J: molecular weight standards. Lanes 4 in I, J: negative controls. Bars in A, B, E–H: 100 mm; Bar in C: 10 mm; Bar in D: 5 mm.
doi:10.1371/journal.pone.0007652.g001
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Figure 2. Double immunolocalization of endothelial and myogenic markers in the interstitial spaces of leech skeletal muscle. (A–E)
Cryosections of unlesioned leech. (F–J) Serial cryosection of injured leeches. Small rounded cells (arrows) dispersed amongmuscle (m) in control animals (A–
E) and close to the regenerating area (arrowheads) in wounded leeches (F–J) express the MyoDmuscle transcriptional factor (green) and the hematopoietic
and endothelial markers CD34 (in red A, F), VE-cadherin (in red B, G), Flk-1 (in red C, H), CD31 (in red D, I). CD68+ cells (in red E, J) areMyoD2 (in green E, J) and
in injured animals (J) are mainly located in the regenerating area (arrowhead). The muscle cells (m) do not express the endothelial or the macrophage
markers (A–E). (K) The percentage of cells expressing myogenic, endothelial and macrophage markers. (L) Expression of CD markers in injured leeches. The
antibodies detected a band of 120 kDa for CD31 (lane 2), 140 kDa for CD34 (lane 3). The molecular weights are in accordance with those of the
corresponding vertebrate molecules. Lanes 1 molecular weight standards. Lanes 4: negative controls. Bars in A–J: 100 mm.
doi:10.1371/journal.pone.0007652.g002
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the region corresponding to the area under the epithelium of the
injection site. Few Dil+ cells were observed in PBS/Dil injected
control animals (Fig. 3F).
Isolation, Characterization and Culture of Cells Dispersed
in the Interstial Muscle Space
In order to follow the fate of Dil-Ac-LDL+ cells and to assess
their potential to differentiate into myogenic cells in vivo and in vitro,
we used the biopolymer matrigel supplemented with VEGF as a
method for isolating these cells in vivo and in vitro [20]. DIL-Ac-
LDL was injected intramuscularly, followed by VEGF supple-
mented matrigel. The biopolymer, removed after one week, was
sparsely colonized by rounded, agranular cells morphologically
similar to vessel-associated precursor cells, as previously described
[20]. These cells were positive for differential May Grunwald
Giemsa staining (Fig. 4A) and took up Dil-Ac-LDL (Fig. 4B).
Once demonstrated that Dil-Ac-LDL+ cells dispersed in the
matrigel biopolymer derived from the muscular interstitial space,
we performed a similar experiment, injecting only matrigel loaded
with VEGF without the previous intramuscular Dil injection. The
matrigel was then removed from the leech after one week, 15 days
or one month from injection and sections of the biopolymer were
immunostained with antibodies to endothelial, myogenic and
macrophage cell markers. The cells infiltrating the matrigel,
removed after one week, expressed the myogenic marker MyoD
along with the endothelial markers either CD34, VE-cadherin or
Flk-1 [7], as demonstrated by double labelling experiments
(CD34/MyoD, VE-cadherin/MyoD, Flk-1/MyoD) on serial
sections (Fig. 4C–E). Further, these cells did not express the
macrophage markers CD11C [27], CD68 [24] or CD14 [28],
whose reactivity with leech macrophages has been previously
demonstrated (see methods) (Fig. 4F–H). Thus the MyoD+ and
endothelial markers positive cells did not show a myeloid
phenotype. No staining was detected in negative control
experiments (Fig. 4I).
Starting from day 15 post MG injection (Fig. 4J–K), the
infiltrated cells exhibited a differentiating phenotype. They showed
an elongated spindle-like shape (Fig. 4J) and highly expressed
desmin (Fig. 4K). Desmin is considered one of the earliest
myogenic markers [29], suggesting commitment toward myogenic
cell differentiation. One month after MG injection, the infiltrated
cells were clearly spindle shaped, showed the typical striations of
skeletal muscle cells (Fig. 4L) and expressed the skeletal muscle
myosin heavy chain (MyHC) (Fig. 4M). Ultrastructural examina-
Figure 3. Dil-Ac-LDL uptake by myoendothelial cells located in the interstitial spaces of leech skeletal muscle and recruited by
VEGF injection. (A–C) Cryosections of unlesioned (A) and injured (B, C) leeches injected with Dil-Ac-LDL. Samples were processed 1 week after
treatment. Dil+ cells (red) are visible dispersed in the ECM surrounding the groups of muscle fibres (m) in control animal (A), close to the regenerating
area (arrowhead in B) and in the lumen of vessels (v in C) in the injured leeches. (D–F) Cryosections of a VEGF/Dil-Ac-LDL injected leech. After one
week from injection new vessels (D) and cells incorporating the vital colorant Dil-Ac-LDL (red in D, E) are visible under the epithelium (e) in the
injected area. In control PBS/DIL injected areas, few Dil+ cells (red in F) are present under the epithelium (e). Nuclei are counterstained with DAPI (blue
in A, B, D–F). Bars in A, B: 100 mm; Bar in D–F: 50 mm.
doi:10.1371/journal.pone.0007652.g003
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Figure 4. Characterization of myoendothelial cells recruited into the matrigel sponges by VEGF. (A, B) Cryosections of MG,
supplemented with VEGF and inoculated in leeches after an intramuscular Dil-Ac-LDL injection. After 1 week in vivo the matrigel implant contains
rounded cells stained with Giemsa (A) and showing uptake of Dil-Ac-LDL (red in B). (C–I) Double labelling on serial cryosections of MG, supplemented
with VEGF and inoculated in leeches. After 1 week in vivo, MG is infiltrated by cells expressing the MyoD muscle transcriptional factor (green in C–E
and in the inserts) and the hematopoietic/endothelial precursor markers either CD34 (red in C and the insert), VE-cadherin (red in D and the insert), or
Flk-1 (red in E and the insert). No staining is detected for the macrophage markers CD11c (red in F) CD68 (red in G) and CD14 (red in H). (I) Negative
control where the primary antibodies were omitted and the secondary antibodies were applied together. After 15 days (J, K), MG is infiltrated by
elongated Giemsa stained cells (J) that expressed desmin (green in K). After 1 month (L–N) groups of differentiated muscle fibres (L) are present in the
MG sponge that are stained by the anti-skeletal MyHC A4.1025 antibody (green in M) and show the contractile material organized in sarcomeres with
TEM (N). Nuclei are counterstained with DAPI (blue in B, K, M). (A1, J1, L1): cryosections of matrigel without VEGF injected as controls. Bars in A, A1, F-
1: 100 mm; Bars in B–E: 50 mm; J, J1, K: 20 mm; Bars in L, L1, M: 10 mm; Bar in N: 2 mm.
doi:10.1371/journal.pone.0007652.g004
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tion confirmed the presence of contractile material organized in
sarcomeres (Fig. 4N). Cellular infiltrates were not observed in
injected matrigel polymer that was not supplemented with VEGF
(Fig. 4A1, J1, L1).
To determine the growth characteristics and differentiation of
the cells infiltrating the matrigel, these cells were clonally isolated
and cultured from the matrigel polymers that had been removed
from the leeches after 1 week in vivo. The rounded agranular cells
that had infiltrated the matrigel sponge in response to VEGF in
vivo (Fig. 5A, A1), were plated out at a low density and allowed to
form colonies over a 24 hr period. After 1 day (Fig. 5B–H) these
cells, grouped in small clones of 1–3 cells, were morphologically
homogeneous (Fig. 5B, H) and stained with Giemsa (Fig. 5C).
They were proliferating as demonstrated by BrdU positivity
(Fig. 5D) and expressed the following associated myogenic and
endothelial markers in double labeling experiments: MyoD/Flk-1
(Fig. 5E), MyoD/VE-cadherin (Fig. 5F) and MyoD/CD34
(Fig. 5G). The percentages of cells MyoD+/Flk1+, MyoD+/VE-
cadherin+, MyoD+/CD34+ were 79%, 78% and 80%, respective-
ly, while the percentages of cells that were MyoD2/Flk1+,
MyoD2/VE-cadherin+, MyoD2/CD34+ were 20%, 21% and
19%, respectively, as determined by counting a mean of 70 cells in
four independent experiments. MyoD+/Flk12, MyoD+/VE-cad-
herin2, MyoD+/CD342 cells were not detected. Distinct colonies
of 1–3 cells were then aspirated using a micropipette and
transferred into 96 well plates to form clonal cultures. After
additional 48 hrs (total 3 days of cultures) the colonies were formed
by 10–15 cells (Fig. 5I). Double labeling experiments showed that
all the cells forming each colony expressed the myogenic and the
endothelial markers MyoD/Flk-1, MyoD/VE-cadherin, MyoD/
CD34 (Fig. 5J–L). The individual colonies of rounded cells were
expanded in vitro and after 8 days from seeding (Fig. 5M–R)
showed two different phenotypes, both rounded and spindle
shaped cells (Fig. 5M). All the cells stained positively with May
Grunwald Giemsa (Fig. 5N), expressed the endothelial marker
CD34 and the muscle precursor markers MyoD (Fig. 5P) and
desmin (Fig. 5Q), while only the rounded cells were proliferating as
demonstrated by BrdU incorporation (Fig. 5O). The presence of
few myosin filaments in the cytoplasm of the elongating cells
(Fig. 5R) was a clear indication that these cells were undergoing a
program of myogenic differentiation. After 15–20 days from
seeding in cell culture (Fig. 5S–W), although most of the cells
showed a highly spindle shaped differentiated phenotype (Fig. 5S,
T) and no longer incorporated BrdU (Fig. 5U), they maintained
both endothelial and myogenic features. Most of these cells still
expressed hematopoietic/endothelial markers such as CD34
(Fig. 5V), and were also positive for the skeletal MyHC (Fig. 5Z).
The percentage of cells MyHC+/CD34+ was 81% as determined
by counting a mean of 40 cells in five independent experiments.
Transmission electron microscopy demonstrated a differentiated
phenotype, showing elongated cells with clearly organized
contractile sarcomeres in the cytoplasm (Fig. 5W). These data
show that clones derived from single cells or small colonies
underwent a differentiation program going from the proliferating
myoendothelial phenotype to a quiescent, muscle phenotype.
Effects of VEGF In Vitro
After being picked with a micropipette, some single cell colonies
were expanded in medium containing VEGF (Fig. 6A–H) to
evaluate the direct effect of this cytokine on the myogenic
differentiation program of the leech myoendothelial cells. In the
presence of VEGF, these cells maintained their undifferentiated
rounded phenotype (Fig. 6A–C), were still viable, as demonstrated
by a Trypan blue exclusion (Fig. 6D) and continued proliferating
as indicated by BrdU incorporation (Fig. 6E–E1). Although these
cells co-expressed desmin and the endothelial markers CD34
(Fig. 6F) or Flk-1, (Fig. 6G), they did not differentiate into muscle
fibers nor did they express skeletal MyHC (Fig. 6H).
In four different experiments seeded with identical cell numbers,
we found that after 20 days, the growth ratio of VEGF–treated
cells was significantly higher than control untreated cells (VEGF,
17.9861.99 vs control, 8.5461.97; p,0.05, n= 4). Statistical
analysis (Fig. 6I) showed that in the presence of VEGF, the
percentage of elongated differentiating cells (as compared to the
rounded undifferentiated cells) was significantly lower with respect
to cells cultured without VEGF (control 16.0662.37% vs. VEGF
2.7461.04%; p,0.01, n= 30 fields).
Discussion
When leech is subjected to a lesion affecting the entire body
wall, a plug constituted by fibroblasts and macrophages is formed
[21,30,31,32,]. Fibroblast activation results in synthesis of a high
levels of ECM, and during the first days of the healing process, a
new robust collagen ‘‘scaffold’’ is produced that directs and
regulates cell migration and guides new vessel formation. Once the
wound is closed, after 1 month from injury, small new muscle
fibres were present in the scarred area and after 2 months the body
wall appears completely regenerated [21].
We examined the origin of these new muscle fibres, since in
leeches no satellite cells, residing in vertebrate muscles and
responsible for regeneration and growth [33,34], have been
detected. Moreover, even if differentiated leech muscle fibres are
able to divide in a very peculiar manner [35], this slow process
cannot be considered an efficient system for a rapid re-
establishment of the muscular body wall.
Like in vertebrates, where the myoendothelial cells are
considered an important source of myogenic precursors [6,7],
also in leeches a similar type of cell is present that participates in a
rapid regeneration of the lesioned muscle. Using immunohisto-
chemical analysis, we documented the presence of cells expressing
the endothelial markers CD34/CD31/VE-cadherin/Flk-1 among
the muscle fibres in unlesioned animals. Moreover, double
labelling immunohistochemical experiments demonstrated that
some of these endothelial cells expressed the myogenic marker
MyoD, suggesting they are a source of myogenic precursors similar
to the myoendothelial cells identified in vertebrates. Consistent
with this concept, only the percentage of endothelial cells
coexpressing MyoD, and not endothelial cells that did not express
MyoD, increased in the injured animals. Further, the endothelial
marker+/MyoD+ cells were mainly located in the regenerating
area. As expected also the percentage of macrophages cells
increased in the lesioned area, but these cells were MyoD2.
Finally, clonal analysis showed that the endothelial marker+/
MyoD+ cells were capable of differentiating into muscle cells in
vitro.
Endothelial and circulating precursor cells, derived from the
leech mesangioblast-like tissue and expressing the hematopietic/
endothelial marker CD34 [17] and the VEGF receptor Flk-1 [15],
have been previously found dispersed in the interstitial space of
leech skeletal muscle. The number of these cells dramatically
increased after lesioning or VEGF administration in the leech
body wall.
To asses a relationship between vessel-associated circulating
precursors and myoendothelial cells, and to follow the fate of these
cells during the regenerating process, we used the vital marker Dil-
Ac-LDL, which is taken up via the ‘‘scavenger cell pathway of
LDL metabolism. This marker has been previously used in
Muscle Regeneration in Leech
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Figure 5. Culture of cells recruited into the matrigel sponges by VEGF. After 1 week in vivo the MG was removed and the cells infiltrating the
matrigel sponge were plated out at a low density and allowed to form colonies over 24 hrs. (A) Phase contrast image of Matrigel extracted after 1
week in vivo. It is infiltrated by numerous rounded cells that stained with Giemsa solution (A1). (B) Phase contrast image of small colonies after 24 hrs
from seeding formed by rounded cells which stained with Giemsa (C) incorporate BrdU in their nuclei (arrowheads in D). (E–G) Double labelling
experiments showing the expression in these cells of the myogenic marker MyoD (green in E–G) and the endothelial markers FLK-1 (red in E), VE-
cadherin (red in F), and CD34 (red in G). (H) TEM micrograph of precursors cells showing an undifferentiated phenotype with large nucleus (n) and
scarce cytoplasm. (I) Phase contrast image of a single colony that was picked with a micropipette and clonally expanded for a total of 3 days in vitro.
(J–L) Double labelling experiments of clonal colonies showing the expression of MyoD (green in J–L) and the endothelial markers FLK-1 (red in J), VE-
cadherin (red in K) or CD34 (red in L). (M) Clonal expansion of single colonies in phase contrast after 8 days in vitro. Rounded (arrowhead) and spindle-
shape cells (arrow) that stained with Giemsa solution (N) are visible. (O) Positivity for BrdU incorporation is detectable only in the nuclei (arrowhead)
of the rounded cells. Double immunofluorescence experiments detect the expression of CD34 (red in P) and MyoD (green in P) in the cultured cells.
These cells are desmin+ as well (red in Q). (R) TEM image showing thick filaments (arrowheads) in differentiating elongated cells. Phase contrast image
(S) and Giemsa staining (T) of spindle-shape cells that dominate the clonal cultures after 20 days in vitro. The differentiating spindle shaped cells are
BrdU2 (U), CD34+ (green in V) and skeletal MyHC+ (red in Z). (W) TEM photomicrograph showing a well differentiated muscle fibre with contractile
material clearly organized into sarcomeres (arrowhead in W). Nuclei are counterstained with DAPI (blue in Q, V, Z). Bars in A–D: 100 mm; Bars in E–G:
20 mm Bars in I–L, V, Z 15 mm; Bars in M–Q, S–U: 10 mm; Bars in H, R, W: 400 nm.
doi:10.1371/journal.pone.0007652.g005
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vertebrates to identify and characterize myoendothelial cells
[6,7,26]. After Dil-Ac-LDL injection in the leech body wall,
DIL+ cells were found dispersed within the muscle interstitial space
of unlesioned leech, migrated towards the wounded region in the
injured leech. A similar effect was obtained by injecting VEGF
along with Dil-Ac-LDL in the body wall of leeches, showing
numerous vessels and DIL-Ac-LDL+ cells migrated into the
stimulated region. The same type of cells also migrated into VEGF
loaded matrigel biopolymers injected into the leeches. One week
after injection, the biopolymer extracted from leeches was invaded
by a homogenous type of cells which took up the vital marker Dil-
Ac-LDL and selectively expressed CD34/MyoD, CD31/MyoD,
VE-cadherin/MyoD, Flk-1/MyoD, but were negative for the
macrophage markers CD14, CD11c and CD68, which have been
previously used to characterize macrophages in leeches [20].
Fifteen days after injection, the extracted matrigel was highly
infiltrated by myocytes expressing desmin and after one month in
vitro, differentiated muscle fibers expressing the skeletal myosin
MyHC were present in the matrigel. Since in leeches the
preexisting mature muscle cells were CD342/CD312/VE-
cadherin2/Flk-12/CD342, we hypothesized that the new differ-
entiated muscle fibres observed in the matrigel biopolymer were
derived from the differentiation of myoendothelial cells and not
from the migration of already differentiated muscle cells.
To confirm this hypothesis we cultured the precursor cells that
had infiltrated the matrigel after 1 week. This approach
demonstrated that matrigel can be used to purify a specific
population of cells showing the morphological features of vessel-
Figure 6. Effect of VEGF on cell differentiation in vitro. (A) Phase contrast image of a single colony that was picked with a micropipette and
clonally expanded for a total of 3 days in vitro being exposed to VEGF from day 1 (B–H): Photomicrographs were obtained from clonally expanded
colonies the were continually exposed to VEGF for a total of 20 days in vitro. (B) Expansion of a single colony in tissue medium. May Grunwald Giemsa
staining (B1) and ultrastructural analysis (C) images show that the cultures consisted largely of rounded undifferentiated cells. (D) The Trypan blue
assay showing that most of cells are viable (excluding the dye) after 20 days in VEGF supplemented medium (the blue background is due to vital dye
precipitation). These cells are proliferating (E) as demonstrated by BrdU incorporation in their nuclei (arrowhead in E1). Double labelling staining
showing the expression of desmin (red in F) and CD34 (green in F) or desmin (red in G) and FLK-1 (green in G). The cells exposed to VEGF in vitro for
20 days are MyHC2 (red in H). Nuclei are stained with DAPI (blue in F, G, H). (I) Quantitative evaluation of elongated cell numbers. Column 1: cells
cultured for 20 days in a VEGF free.medium. Column 2: cells cultured for 20 days in a VEGF supplemented medium.*p,0,01 with respect to the
control. Bars in A: 20 mm; Bars in B, D, E, F–H: 100 mm; Bars in B1, E1: 10 mm; Bar in C: 400 nm.
doi:10.1371/journal.pone.0007652.g006
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associated precursor cells. We then isolated individual cell colonies
from the extracted matrigel and we cultured them in vitro for
several days and analyzed them morphologically and immunohis-
tochemically. After 24 hrs of culture, most of the proliferating cells
forming these colonies expressed the same markers of vertebrate
myoendothelial cells [7]. The MyoD+/Flk-1+, MyoD+/VE-
cadherin+, MyoD+/CD34+ cells, cultured in a normal medium,
spontaneously differentiated into muscle fibres after 15–20 days,
while the same type of cells cultured in a medium supplemented
with VEGF maintained their undifferentiated phenotype and
continued to proliferate.
The main conclusion of this study is that the circulating
precursor cells involved in endothelial cell differentiation and
contributing to neovascularization during wound healing or after
cytokine stimulation [17] can also differentiate into muscle cells
and significantly contribute to muscle regeneration in leeches. We
hypothesized that the improved myogenic potential of precursors
cells is due to their higher proliferation rate, as opposed to the
limited proliferative capacity of differentiated muscle fibres.
The apparent different myogenic and endothelial destinies of
these precursor cells could be due to differential responses to
VEGF concentrations, as suggested previously [15]. These cells
can be driven toward a myogenic differentiation pathway,
depending on the time course of VEGF released to target cells.
When CD34+/CD31+/Ve-cadherin+/Flk-1+ cells are exposed to a
sustained and continuous source of VEGF, slowly diffusing from
injected matrigel or perhaps from physiological ECM ‘‘sinks’’, they
proliferate and principally maintain their undifferentiated pheno-
type as precursor cells. As the VEGF concentration decreases
(inside the matrigel, or in the ECM surrounding the muscle fibres)
the proliferation stimulus diminishes, permitting these hematopoi-
etic/endothelial precursors cells to then differentiate into muscle
fibres. The secretion of VEGF during wound healing could be
interpreted as a strategy for recruitment and expansion of muscle
progenitor cells as supported by the cell culture experiments. Thus
the CD34+/CD31+/VE-cadherin+/Flk-1+ cells posses the capacity
to activate diverse genetic programs in response to peculiar
environmental stimulation.
Interestingly, VEGF signalling seems to play the same role in
vertebrates, modulating the migration, proliferation and survival
of both endothelial and myogenic precursors cells into muscle
regenerating areas [36,37].
Taken together, these results suggest that: i) the hematopoietic/
myoendothelial MyoD+/Flk-1+, MyoD+/VE-Cadherin+, MyoD+/
CD34+ cells have the ability to directly participate in myogenesis
both in vivo and in vitro; ii) VEGF secretion, while promoting stem
cell recruitment and expansion, does not seem to be involved in
inducing myogenic differentiation of myoendothelial cells; iii) leech
hematopoietic and endothelial precursor cells share with verte-
brates the same morphofunctional and molecular mechanisms,
indicating that leeches can be considered a simple model for
studying the regulating myoendothelial cell biology step by step.
Materials and Methods
Animals and Treatments
Leeches (Hirudo medicinalis, Annelida, Hirudinea, from Ricar-
impex, Eysines, France) measuring 1061 cm were kept in water at
19–20uC in aerated tanks. Animals were fed weekly with calf
blood. Animals were randomly divided into separate experimental
groups according to different protocols and treatments. Each
treatment was performed at the level of the 80th superficial
metamere. Before each experiment, leeches were anaesthetized
with a 10% ethanol solution.
Group (1): 5 untreated leeches that served as controls.
Group (2): 5 injured leeches; the animals were subjected to
lesions consisting of a tissue explant (26262 mm) affecting the
entire body wall. The tissue explant was surgically removed with
microdissecting scissors.
Group (3): 10 injured animals injected with the vital marker
specific for endothelial and macrophages cells Dil-Ac-LDL
(Acetylated Low Density Lipoprotein, Biomedical Technologies
Inc., MA, USA). To functionally characterize the cells migrating
into the injured area, animals were injected with 10 ml of a Dil-Ac-
LDL solution (10 mg/ml in phosphate buffer (PBS) and after 4 h
(corresponding to a suitable time necessary for the colorant to
diffuse in the body wall of the animal, [20] the leeches were
surgically wounded in the same region.
Group (4): 10 vascular endothelial factor (VEGF) injected
animals. To functionally characterize the cells migrating under the
influence of VEGF, the leeches were injected with the vital dye
Dil-Ac-LDL (as above), and after 4 hours with 300 ml of PBS
containing 100 ng/ml of VEGF165 (Pepro Tech, London, UK) in
the same area.
Group (5): 10 untreated leeches injected only with Dil-Ac-LDL
solution, as controls for both injured/Dil-Ac-LDL injected and to
VEGF/Dil-Ac-LDL injected animals.
Group (6): 10 animals injected with Dil-Ac-LDL and Matrigel
(MG) supplemented with VEGF. To selectively isolate the cells
migrating under the influence of VEGF165, the leeches were
injected with 10 ml of Dil-Ac-LDL (10 mg/ml in PBS buffer
0.01 M) and after 4 h were inoculated in the same area with
300 ml of MG (an extract of the murine Engelbreth-Holm-Swarm
(EHS) tumor produced as previously described [38]) supplemented
with 100 ng/ml of VEGF165, as previously described [20].
Group (7): 10 control matrigel injected animanls. The healthy
leeches were injected only with liquid Matrigel (MG) that was not
supplemented with the cytokine.
The animals were sacrificed after either 1 week, 15 days or 1
month from treatment, the stimulated areas or theMG implants were
removed from the animal and processed for electron microscopy or
embedded in Polyfreeze tissue freezing medium (Polysciences,
Eppelheim, Germany) and immediately frozen in liquid nitrogen.
Cryosections (7 mm) obtained with a Leica CM 1850 were
stained by differential staining (May Grunwald Giemsa, Bio
Optica, Milano, Italy) or by immunocytochemistry to identify
myoendothelial cells. Dil-Ac-LDL uptake was visualized on a
fluorescence microscope Olympus BH2 through a rhodamine
filter set (excitation/emission filters 550/580 nm). Images were
acquired with a DS-5M-L1 Nikon digital camera system.
Trasmission Electron Microscopy (TEM)
Samples were fixed for 2 h in 0.1 M cacodylate buffer pH 7.2,
containing 2% glutaraldehyde. Specimens were then washed in
the same buffer and postfixed for 2 h with 1% osmic acid in
cacodylate buffer, pH 7.2. After standard serial ethanol dehydra-
tion, specimens were embedded in an Epon-Araldite 812 mixture.
Sections were obtained with a Reichert Ultracut S ultratome
(Leica, Wien, Austria). (Olympus, Tokyo, Japan). Thin sections
were stained by uranyl acetate and lead citrate and observed with
a Jeol 1010 EX electron microscope (Jeol, Tokyo, Japan).
Indirect Immunofluorescence Staining
Cryosections of healthy, injured, Dil-Ac-LDL andVEGF injected
leeches and cultured cells (the latter fixed with 4% paraformalde-
hyde in PBS for 30 min at 4uC) were pre-incubated for 30 min with
phosphate-buffer (PBS) containing 2% bovine serum albumin (BSA)
before the primary antibody incubation (4uC over night). The
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primary antibodies used were: mouse anti-human CD31, CD34,
Flk-1 and VE-cadherin (1:20, Santa Cruz Biotechnology, CA,
USA); which reacts with leech endothelial cells, as previously
demonstrated [14,15,17,25]), mouse anti-humanCD14 (1:20, Santa
Cruz Biotechnology), mouse anti-human CD68 (1:20, DBA,
Segrate, MI, Italy) and CD11c (1:20, Novocastra laboratories,
Newcastle upon Tyne UK) (which react with leech macrophages, as
previously demonstrated [17,25]), rabbit anti-human desmin (1:100,
Sigma, St. Louis, MO) which reacts with leech obliquely striated
muscles fibres, as previously demonstrated [39], mouse anti-human
A4.1025 (1:10, Santa Cruz Biotechnology) which recognises many
(if not all) sarcomeric skeletal myosin (MyHCs) in species from
Drosophila to human and a rabbit anti-mouse MyoD (1:20, Santa
Cruz Biotechnology). The washed specimens were incubated for
1 h at room temperature with the appropriate secondary antibody
(Jackson, Immuno Research Laboratories, West Grove, PA, USA)
that was Cy3 or FITC (fluorescein isothiocyanate) conjugated
(dilution 1:100). In double labelling experiments, the primary
antibodies mouse anti-human CD31 or CD34 or Flk-1 or VE-
cadherin or CD14 or CD68 or CD11c, were incubated together
with the primary antibody rabbit anti-mouse MyoD. After washing,
the secondary antibodies donkey anti-mouse Cy3 conjugated and
donkey anti-rabbit FITC conjugated were applied together on the
sections. In cultured cells double staining with mouse anti-human
CD34 and mouse anti-human A4.1025 was performed as described:
anti CD34 was applied first, then cells were incubated with the
secondary antibody goat anti-mouse FITC conjugated. After
washing the cells were incubated with the antibody anti A4.1025
and subsequently, with the secondary Cy3 conjugated goat anti-
mouse antibody. Nuclei were stained by incubating for 15 min with
49,6-Diamidino-2-Phenylindole (DAPI, 100 ng/ml in PBS, Sigma).
The PBS buffer used for the washing steps and antibody dilutions
contained 2% BSA. Slides were mounted in Citifluor (Citifluor Ltd,
London, UK) with coverslips and examined with fluorescence
microscope Olympus BH2 (Olympus, Tokyo, Japan). The staining
was visualized using excitation/emission filters 550/580 nm for
Cy3, 490/525 nm for FITC and 340/488 nm for DAPI. Data were
recorded with a DS-5M-L1 digital camera system (Nikon, Tokyo,
Japan). Images were combined with Adobe Photoshop (Adobe
Systems, Inc.). In control samples, primary antibodies were omitted
and sections, pre-incubated for 30 min with PBS/BSA, were
incubated only with the secondary antibodies. In the double
labelling experiments the two types of secondary antibodies were
applied together.
Biochemical Procedures
The body walls of leeches were dissected into small pieces and
homogenised in liquid nitrogen with a mortar. Rat skeletal muscle,
used as a positive control, was homogenised following the same
protocol. For SDS-polyacrylamide gel electrophoresis (SDS-
PAGE), homogenates were suspended in extraction buffer
(0.4 M NaCl, 5 mM MgCl2,1 mM EDTA, 0.5 mg/ml pepstatin,
50 mM Tris HCl, pH 7.2 with 1 mM phenylmethylsulphonyl
fluoride and 0.2 mM ATP freshly added); particulate material was
removed by centrifugation at 13000 rpm for 10 min at 4uC in a
refrigerated Sorvall RCM14 microcentrifuge. Supernatants were
denatured in 2X sample buffer (2% SDS, 10% b-mercaptoetha-
nol, 0.002% bromophenol blue, 20% glycerol, 0.02 M Tris HCl
pH 6.8) at 100uC for 5 min.
SDS-PAGE
Analytical SDS-PAGE using 15% (for MyoD detection), 5% (for
skeletal myosin detection) and 7.5% (for CD markers detection)
acrylamide mini gel was made according to [40]. Molecular
weights were determined by concurrently running, for the 15%
mini gel, the Prestained SDS-PAGE Standard Broad Range (BIO-
RAD, Hercules, CA) and, for the 5% and 7.5% min gel, the
Novex Sharp Prestained Standard (Invitrogen, San Giuliano
Milanese, MI, Italy). Electrophoresis was made at 200 V for 1 h.
Western Blot
Proteins separated by SDS-PAGE were transferred onto Bio-Rad
nitrocellulose filters according to [41]. Before immunostaining, the
membranes were saturated with 5% BSA in Tris-buffered saline
(TBS, 20 mM Tris-HCl buffer, 500 mM NaCl pH 7.5) at room
temperature for 2 h. Nitrocellulose membranes were incubated
overnight at 4uC with the primary antibodies: rabbit anti-mouse
MyoD (Santa Cruz Biotechnology) or mouse anti-human A4.1025
(Santa Cruz Biotechnology), at a 1:250 dilution or with the mouse
anti-human CD34, CD31, antibodies (Santa Cruz Biotechnology) at
a 1:50 dilution in 2% TBS-BSA. After three washes of the membrane
with TBS, antigens were revealed with peroxidase-conjugated
secondary antibodies (1:500): a donkey anti-rabbit for MyoD,
(Jackson ImmunoResearch Laboratories) and a donkey anti-mouse
for CD 31, CD34 and A4.1025 (Jackson ImmunoResearch
Laboratories). After washing with TBS, signal was developed with
chemiluminescent substrate (Pierce, Rockford, IL, USA). Stainings
without the primary antibodies were performed as controls.
Cultured Cells and In Vitro Assays
Ten leeches were injected at the level of the 80th superficial
metamere with 300 ml of Matrigel (MG) added with100 ng/ml
VEGF165. After 1 week Matrigel implants were harvested from the
animals, minced in small pieces using sterilized razor blades and
mechanically dissociated with a micropipette in 400 ml of tissue
culture medium [20]. To obtain single cell colonies for clonal
analyses, cells were plated out at a low density (20/cm2) for 24 hrs
and maintained at 20uC as previously described [20]. The distinct
and well separated colonies of 1–3 cells that formed were then
individually aspirated with a pulled glass capillary connected to a
microinjector (Nanoject 2000, WPI, Germany), transferred to a
single well of 96 well plates in 200 ml of tissue culture medium. After
additional 72 hrs (3 days in vitro) some colonies were processed for
histological and immunocytochemical analysis, while others were
passaged into 24 wells plates and grown for additional 5 days (8 days
in vitro) or 17 days (20 days in vitro) and processed as above.
To evaluate the effect of VEGF165 on cell proliferation and
differentiation, colonies formed from single cells isolated from MG
implanted 1 week as described above, were plated and expanded
in 24-multiwell plates in medium alone or in medium supple-
mented with 100 ng/ml of VEGF165. All cultures were performed
in quadruplicate and scored at 20 days in vitro using an inverted
Olympus microscope. Data were recorded with a DS-5M-L1
digital camera system (Nikon).
Assessment of Cell Viability with Trypan Blue
Cell viability was assessed using the vital dye Trypan blue,
which is incorporated only in dying or dead cells. The cells were
incubated at room temperature for 5 min with 0.4% trypan blue
solution (diluted 1:1 in basal medium) and directly observed using
an inverted optical microscope (Olympus). Data were recorded
with a DS-5M-L1 digital camera system (Nikon) within three
minutes after from staining.
Proliferation Assay
Cells, according to manufacturer’s protocol (Amersham-Phar-
macia, Buckinghamshire, UK), were incubated at 20uC for 1 h
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with the labeling medium (aqueous solution of 5-bromo-29-
deoxyuridine (BrdU) and 5-fluoro-29-deoxyuridine 10:1), washed
in PBS and fixed in acid-ethanol (90% ethanol, 5% acetic acid, 5%
water) for 30 min. After washing in PBS, cell proliferation was
monitored by using a monoclonal mouse anti-5-bromo-29-
deoxyuridine and a secondary antibody anti-mouse IgG2a HRP-
conjugated to detect BrdU incorporation into cellular DNA.
Signal was developed with a DAB solution and cells were
examined with Olympus BH2 microscope (Olympus). Controls
were performed by omitting the primary antibody.
Statistical Analysis
In each section of four independent experiments the percentage
of rounded cells co-expressing endothelial markers and the
myogenic marker MyoD was calculated as follows: the total
number of rounded cells stained by endothelial markers and the
total number of cells co-expressing the endothelial and myogenic
marker were counted by hand, using the Image J software
package, (http://rsbweb.nih.gov/ij/download.html). The value of
cells co-expressing the myogenic and endothelial marker was
divided by the value of total number of cells expressing the
endothelial markers.
For proliferation studies in vitro, cells belonging to single colonies
were re-plated at a very low density of 20/cm2. Control cultures
VEGF-treated cultures were counted after 20 days and the mean
proliferation index has been computed by the ratio between the
number of cells recorded after 20 days with the number of cells
plated at day zero.
For the differentiation test, the total surface of the cultured wells
was sampled in 30 fields of 87.000 mm2 each. Cells in each field
were counted using the Image J software package and classified
into round or elongated class according to their phenotype. For
each field, the percentage of elongated cells on the total cell count
has been calculated. Data represent the mean6SEM of the single
field percentages. Statistical significance was assessed by an
unpaired Student’s t test using Origin 5.0 software (Microcal).
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